Cargando…

A snapshot on the usage pattern of gabapentinoids in Oman

BACKGROUND: Since their introduction as adjunct anticonvulsants, the use of gabapentinoids (gabapentin and pregabalin) has increased substantially worldwide to include a wide range of clinical conditions. Various reports have demonstrated that they possess addiction liability and can produce effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Badi, Abdulaziz Said Al, Hashar, Amna Al, Riyami, Intisar Al, Za’abi, Mohammed Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851813/
https://www.ncbi.nlm.nih.gov/pubmed/36733519
http://dx.doi.org/10.18549/PharmPract.2022.3.2693
_version_ 1784872485809815552
author Badi, Abdulaziz Said Al
Hashar, Amna Al
Riyami, Intisar Al
Za’abi, Mohammed Al
author_facet Badi, Abdulaziz Said Al
Hashar, Amna Al
Riyami, Intisar Al
Za’abi, Mohammed Al
author_sort Badi, Abdulaziz Said Al
collection PubMed
description BACKGROUND: Since their introduction as adjunct anticonvulsants, the use of gabapentinoids (gabapentin and pregabalin) has increased substantially worldwide to include a wide range of clinical conditions. Various reports have demonstrated that they possess addiction liability and can produce effects similar to traditional recreational drugs, such as significant euphoric effects, enhanced sociability, and relaxation. However, there is limited information on the use of these agents in the Middle East. OBJECTIVES: Here, we describe the usage pattern of gabapentinoids at Sultan Qaboos University Hospital, a tertiary care medical institution in Oman. METHODS: Adult patients (≥18 years) who were prescribed gabapentinoids for six months (March–August 2019) were included in this retrospective cross-sectional study. Indications and dosing regimens were reviewed according to the Food and Drug Administration labeling. Controlled and restricted drugs were reviewed using Oman National Formulary. Institutional ethical approval was obtained before conducting the study. RESULTS: We analyzed 291 prescriptions. The mean (standard deviation, SD) age was 60.5 years (SD = 13.0) with the age group of ≥60 years being the most common (190, 65.3%). Most of patients were females (178, 61.2%). The majority of prescriptions were for outpatients (85.8%). Drugs were prescribed as refill and follow-up in 116 (40.0%) and 97 (33.4%) of prescriptions, respectively. Diabetic peripheral neuropathy (50, 79.4%) was the most labeled indication for both. Off-label use was 128 (51.8%) and 31 (70.5%) for pregabalin and gabapentin, respectively, with lower back pain as being the most common indication for both drugs. A total of 54 (19.0%) patients were using at least one of the psychotropic drugs. CONCLUSIONS: Our findings indicate that gabapentinoids are frequently prescribed for off-label use. Awareness programs and the establishment of policy for the use of these drugs are required to ensure their rational use and prevent misuse and/or abuse.
format Online
Article
Text
id pubmed-9851813
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-98518132023-02-01 A snapshot on the usage pattern of gabapentinoids in Oman Badi, Abdulaziz Said Al Hashar, Amna Al Riyami, Intisar Al Za’abi, Mohammed Al Pharm Pract (Granada) Original Research BACKGROUND: Since their introduction as adjunct anticonvulsants, the use of gabapentinoids (gabapentin and pregabalin) has increased substantially worldwide to include a wide range of clinical conditions. Various reports have demonstrated that they possess addiction liability and can produce effects similar to traditional recreational drugs, such as significant euphoric effects, enhanced sociability, and relaxation. However, there is limited information on the use of these agents in the Middle East. OBJECTIVES: Here, we describe the usage pattern of gabapentinoids at Sultan Qaboos University Hospital, a tertiary care medical institution in Oman. METHODS: Adult patients (≥18 years) who were prescribed gabapentinoids for six months (March–August 2019) were included in this retrospective cross-sectional study. Indications and dosing regimens were reviewed according to the Food and Drug Administration labeling. Controlled and restricted drugs were reviewed using Oman National Formulary. Institutional ethical approval was obtained before conducting the study. RESULTS: We analyzed 291 prescriptions. The mean (standard deviation, SD) age was 60.5 years (SD = 13.0) with the age group of ≥60 years being the most common (190, 65.3%). Most of patients were females (178, 61.2%). The majority of prescriptions were for outpatients (85.8%). Drugs were prescribed as refill and follow-up in 116 (40.0%) and 97 (33.4%) of prescriptions, respectively. Diabetic peripheral neuropathy (50, 79.4%) was the most labeled indication for both. Off-label use was 128 (51.8%) and 31 (70.5%) for pregabalin and gabapentin, respectively, with lower back pain as being the most common indication for both drugs. A total of 54 (19.0%) patients were using at least one of the psychotropic drugs. CONCLUSIONS: Our findings indicate that gabapentinoids are frequently prescribed for off-label use. Awareness programs and the establishment of policy for the use of these drugs are required to ensure their rational use and prevent misuse and/or abuse. Centro de Investigaciones y Publicaciones Farmaceuticas 2022 2022-08-23 /pmc/articles/PMC9851813/ /pubmed/36733519 http://dx.doi.org/10.18549/PharmPract.2022.3.2693 Text en Copyright: © Pharmacy Practice https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Badi, Abdulaziz Said Al
Hashar, Amna Al
Riyami, Intisar Al
Za’abi, Mohammed Al
A snapshot on the usage pattern of gabapentinoids in Oman
title A snapshot on the usage pattern of gabapentinoids in Oman
title_full A snapshot on the usage pattern of gabapentinoids in Oman
title_fullStr A snapshot on the usage pattern of gabapentinoids in Oman
title_full_unstemmed A snapshot on the usage pattern of gabapentinoids in Oman
title_short A snapshot on the usage pattern of gabapentinoids in Oman
title_sort snapshot on the usage pattern of gabapentinoids in oman
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851813/
https://www.ncbi.nlm.nih.gov/pubmed/36733519
http://dx.doi.org/10.18549/PharmPract.2022.3.2693
work_keys_str_mv AT badiabdulazizsaidal asnapshotontheusagepatternofgabapentinoidsinoman
AT hasharamnaal asnapshotontheusagepatternofgabapentinoidsinoman
AT riyamiintisaral asnapshotontheusagepatternofgabapentinoidsinoman
AT zaabimohammedal asnapshotontheusagepatternofgabapentinoidsinoman
AT badiabdulazizsaidal snapshotontheusagepatternofgabapentinoidsinoman
AT hasharamnaal snapshotontheusagepatternofgabapentinoidsinoman
AT riyamiintisaral snapshotontheusagepatternofgabapentinoidsinoman
AT zaabimohammedal snapshotontheusagepatternofgabapentinoidsinoman